KD Nutra announce completion of a clinical trial for its Move3 omega-3 joint formulation

22 April 2019

Omega-3 and sports performance – Clinically proven formula Move3 improves pain, stiffness and cartilage damage related to exercise 

KD Nutra is pleased to share exciting news with you about our Move3 joint health formulation. A recently completed clinical trial has shown that the omega-3 and NEM eggshell membrane formulation has a significant impact in sports performance and exercise recovery.

Conducted on an exercising healthy population, the clinical trial* demonstrates that Move3 improves recovery from exercise-induced joint pain and stiffness, and significantly reduces discomfort immediately following exercise. It also demonstrated a significant decrease in CTX-II, a biomarker of cartilage degradation.

Subjects in the trial saw improvements after 3 days and sustained benefits for more than two weeks after exercise. Cartilage damage was significantly reduced after 1 and 2 weeks. Consumers taking this product experienced less pain and stiffness from exercise while maintaining cartilage health.

 

“This trial demonstrated important improvements in subjective measures of exercise recovery, as well as hard biomarkers of exercise-induced damage to joints,” noted Adam Ismail, Chief Strategy Officer of KD Pharma.  “Importantly, the effects were not only seen shortly after the exercise event, but also sustained over the course of the trial, meaning weekend warriors and serious athletes alike should consider the product to protect their active lifestyles.”

 

Move3 represents the combination of two flagship ingredients from KD Nutra and Stratum Nutrition. The benefits of KD-Pür® omega-3 EPA/DHA from fish oil in conjunction with NEM® brand eggshell membrane are combined to support joint health from two angles.

Because healthy people have joint pain too, Move3 has been created as a novel combination of ingredients aims to meet today’s consumer demands for joint health.

The study is currently in the process of being submitted for publication in a peer-reviewed journal.

 

Takeaways:

  • Move3 is a custom-crafted KD-Pür® omega-3 blend with NEM® brand eggshell membrane for joint health.
  • Healthy men and women are better able to maintain an active lifestyle when taking Move3.
  • Improvements were seen after 3 days and a marker of cartilage damage was significantly reduced after 1 and 2 weeks.
  • Effects were quick and maintained over time.

* Conducted under license from ESM Technologies, LLC (U.S. Patent 9,983,214). 

 

Want to discover more about our Move3 clinical trial?

Don't miss our presentation at Vitafoods Europe

Speakers: Adam Ismail (Chief Strategy Officer of the KD Pharma Group) and Micah Osborne (President at Stratum Nutrition).

  • When: 7 May 2019 at 15:00 pm
  • Where: Sports Nutrition Theater – Stand M2

 

Meet with us at Vitafoods Europe!

KD Nutra is participating in Vitafoods. We have several exciting new product offerings that we are eager to share with you. Let's discuss how we can help you innovate & achieve success in 2019. Make an appointment today!

  • When: 7-9 May 2019
  • Where: Genève, Switzerland
  • Booth: J42

Contact us at info@kdpharmagroup.com or call us at +49 (0) 6826 979700 for EU / +1 570 260 6900 for USA / +86 13321813230 for Asia